CASI PHARMACEUTICALS, INC. Shareholders' Equity
CASI PHARMACEUTICALS, INC. (CASIF) had Shareholders' Equity of -$37.28 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-15
- 2025-12-31: Stockholders' Equity Attributable to Parent -$37.28M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $1.85M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $24.16M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $44.57M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | -$37.28M 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.85M 20-F · filed 2026-05-15 |
| 2023-12-31 | $24.16M 20-F · filed 2026-05-15 |
| 2022-12-31 | $44.57M 20-F · filed 2026-05-15 |
| 2021-12-31 | $84.50M 20-F · filed 2025-03-31 |
| 2020-12-31 | $81.54M 20-F · filed 2024-03-28 |
| 2019-12-31 | $73.00M 20-F · filed 2023-04-26 |